Arterial Adventitial Vasa Vasorum Density Reflects The Progression Of Unstable Plaques: A Retrospective Clinical

Jiemei Yang1, Penghao Gao2, Qiannan Li3

  • 1Department of Cardiology, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, P.R. China; Cardiac Ultrasound Division, the First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, P.R. China.

PubMed

Insights

Arterial adventitial vasa vasorum (AVV) density in carotid arteries indicates atherosclerosis severity. Sonodynamic therapy (SDT) effectively reduces AVV hyperplasia and shrinks atherosclerotic plaques in human lesions.

Area of Science:

  • Vascular Biology
  • Cardiovascular Disease
  • Medical Imaging

Background:

  • Arterial adventitial vasa vasorum (AVV) is implicated in atherosclerosis (AS) development, but effective anti-AVV therapies are lacking.
  • AS is a systemic vascular disease involving multiple sites, not just local plaque formation.
  • Current understanding of AVV's role in carotid AS and potential therapeutic interventions requires further investigation.

Purpose of the Study:

  • To determine if human carotid AVV density correlates with plaque neovascularization and intimal-media hyperplasia.
  • To investigate the efficacy of sonodynamic therapy (SDT) in reducing human AVV density.

Main Methods:

  • A retrospective study of 160 carotid atherosclerosis patients.
  • Utilized duplex ultrasound scanning (DUS), contrast-enhanced ultrasound (CEUS), coronary angiography, and CT angiography (CTA).
  • Employed Pearson correlation and ROC curve analysis to assess AVV/VV hyperplasia and intima-media thickness (IMT); developed SDT for treatment.

Main Results:

  • Local AVV presence in carotid plaques correlated with plaque echogenicity, progression, and acute coronary syndrome (ACS) events.
  • AVV hyperplasia in carotid plaques was associated with coronary artery stenosis.
  • SDT demonstrated a reduction in local AVV hyperplasia and plaque size in femoral and carotid lesions.

Conclusions:

  • AVV presence in human carotid arteries reflects the severity of both carotid and coronary artery AS.
  • SDT is a potential therapeutic approach to reduce AVV hyperplasia and mitigate AS progression in human arteries.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...